Cite
HARVARD Citation
Bicakli, D. et al. (n.d.). Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. Journal of oncology pharmacy practice. pp. 46-53. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bicakli, D. et al. (n.d.). Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. Journal of oncology pharmacy practice. pp. 46-53. [Online].